Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Recombinant fragment contains a sequence corresponding to a region within amino acids 130 and 448 of LRIG3|
|Purification||Antigen affinity chromatography|
|Storage buffer||PBS, pH 7, with 20% glycerol|
|Storage Conditions||-20° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|Western Blot (WB)||1:500-1:3000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
PA5-34865 targets LRIG3 in WB applications and shows reactivity with Human samples.
The PA5-34865 immunogen is recombinant fragment contains a sequence corresponding to a region within amino acids 130 and 448 of LRIG3.
May play a role in craniofacial and inner ear morphogenesis during embryonic development. May act within the otic vesicle epithelium to control formation of the lateral semicircular canal in the inner ear, possibly by restricting the expression of NTN1 .
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
leucine-rich repeats and immunoglobulin like domains 3; leucine-rich repeats and immunoglobulin-like domains 3; leucine-rich repeats and immunoglobulin-like domains protein 3; LIG-3; UNQ287/PRO326/PRO335, LIG3, LIG-3
LIG3; LRIG3; UNQ287/PRO326/PRO335